2Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J].Circulation,2003,107 (3):499 -511.
3Pearson TA,Blair SN,Daniels SR,et al.American Heart Association guidelines for primary prevention of cardiovascular disease and stroke:2002 update:consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases.American Heart Association Science Advisory and Coordinating Committee[J].Circulation,2002,106 (3):388-391.
4Hatanaka K,Li XA,Masnda K,et al.Immunohistochemical localization of C-reactive protein binding sites in human aortic lesions by a modified streptavidin biotinstaining method[J].Pathol Int,1995,45(7):631-641.
5Rebuzzi AG,Quarante L,Liuzzo G,et al.Incremental prognostic value of serum levels of tropinin T and C-reactive protein on admission in parients with unstable angina pectoris[J].Am J Cardiol,1998,82(5):715-719.
二级参考文献17
1Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C- reactive protein and serum anyloid A protein in severe umstable angina[J] .N Eng J Med,1994,331(3) :417-424.
2Thompson SG, Kienast J, Pyke SOM, et al. Uemostatic factors and the risk of myocardial infarction or solden death in patients with angina pectoris[ J]. N Eng J Med, 1995,332(4) :635-641.
3Rus H, Niculescu FI. Inflammation, aspirin, and the risk of cardiovascular disease[J] .N Eng J Med,1997,337(3) :423.
4Luigi M, Giovanna L, Rita L, et al. Elevated levels of C-creaetive protein at discharge in patients with unstable angina predict recurrents instsbility[J]. Clin Invest Rep, 1998,11(5) : 855-859.
5Rebuzzi AG, Quarante L, Liuzzo G, et al. Incremental prognostic value of serum levels of tropinin T and C-creactive protein on admission in patients with unstable angina pectoris[ J] .Am J Cardiol, 1998,82(5) :715-719.
6Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-creactive protien at discharge in patient with unstable angina pectoris recurrent instability[J]. Criculation, 1999,99(20) :2079- 2084.
7Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently health men[J]. N Eng J Med, 1997,336(14) :973-979.
8Marrow DA, Rifai N, Antman EM, et al. C-reactive protent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI HA subs-tudly [ J ]. J Am Coll Cardiol,1998,31 (5) : 1460-1465.
9Gaspardone A, Crea F, Versaci F, et al. Preadictive value of C-creacrive protein after successful coronary- artery stenting in patient with unstable angina[J]. Am J Cardiol, 1998,82(3) :515- 518.
10Koenig W, Sund M, Frohlich M, et al. C-creacyive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy midle-aged men : Resolts from the MONICA angsburg cohort study 1984-1992 [ J]. Circulation, 1999,99(2) : 237-242.
7Almagor M,Keren A,Banai S.Increased C-reactive protein level after coronary stentimplantation in patients with stable coronary artery disease[J].Am HeartJ,2003,145(2):248-253.
8Aviles RJ,Martin DO,Apperson-Hansen C,et al.Inflammation as a risk factor for atrialfibrillation[J].Circulation,2003,108 (24):3006-3010.
9Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and eardiovascular disease: Application to clinical and public heahh practice: a statement for heahhcare professionals from the centers for disease control and prevention and the American Heart Association [J]. Circulation 2003, 107:499 - 511.
10Yamashina A, Tomiyama H, Takeda K, et al. Validity, reprodueibility, and clinical significance of non - invasive braehial - ankle pulse wave velocity measurement[J]. Hypertension Research, 2002, 25:359 - 364.
